Skip to main content

Table 7 Mean per patient costs

From: Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece

 

Strategy 1

Strategy 2

Pharmaceutical cost

€2853

€2427

Comorbidities costs

€4393

€4539

Ischaemic heart disease cost

€371

€ 343

Myocardial infarction cost

€1235

€1242

Congestive heart failure cost

€340

€316

Stroke cost

€1168

€1186

Amputation cost

€36

€30

Renal failure cost

€1243

€1422

Adverse events costs

€2757

€3111

Non-severe hypoglycemia cost

€19

€29

Severe hypoglycemia cost

€126

€179

Monitoring costs

€2611

€2903

Total costs

€10,003

€10,077